| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039381316 |
| P356 | DOI | 10.1038/SJ.BJC.6690064 |
| P932 | PMC publication ID | 2362446 |
| P698 | PubMed publication ID | 10027306 |
| P5875 | ResearchGate publication ID | 13262871 |
| P2093 | author name string | Vähäkangas K | |
| Savolainen ER | |||
| Koistinen P | |||
| Castren K | |||
| Säily M | |||
| Zheng A | |||
| P2860 | cites work | The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13) | Q24633330 |
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
| Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Participation of p53 protein in the cellular response to DNA damage | Q29618319 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| Localization of gene for human p53 tumour antigen to band 17p13. | Q34179671 | ||
| Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies | Q34400583 | ||
| Database of p53 gene somatic mutations in human tumors and cell lines | Q34868968 | ||
| p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression | Q35977771 | ||
| Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics | Q35977787 | ||
| Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells | Q36322555 | ||
| Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage | Q36557538 | ||
| Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation | Q36564865 | ||
| Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability | Q36564973 | ||
| Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway | Q36648425 | ||
| Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents | Q38319213 | ||
| Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells | Q40237209 | ||
| A transcriptionally active DNA-binding site for human p53 protein complexes | Q40655196 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. | Q41205685 | ||
| How phosphorylation regulates the activity of p53. | Q41206472 | ||
| Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form | Q41210647 | ||
| p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines | Q41305946 | ||
| Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene | Q41470010 | ||
| Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells | Q41483255 | ||
| Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? | Q41513765 | ||
| Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents | Q41575832 | ||
| Constitutive expression of p53 protein in enriched normal human marrow blast cell populations | Q41628815 | ||
| Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication | Q44703400 | ||
| Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer | Q45066172 | ||
| High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis | Q47630133 | ||
| Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein | Q47751193 | ||
| Mechanisms of p53 alteration in acute leukemias | Q52507505 | ||
| Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. | Q53438154 | ||
| Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. | Q53491590 | ||
| Mutations of the P53 gene in acute myeloid leukaemia | Q68077839 | ||
| Frequent mutations in the p53 gene in human myeloid leukemia cell lines | Q68104797 | ||
| Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation | Q70168032 | ||
| In vivo ubiquitination and proteasome-mediated degradation of p53(1) | Q71129152 | ||
| A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation | Q71169980 | ||
| Disappointments in treating acute leukemia in the elderly | Q71694659 | ||
| p53-dependent apoptosis suppresses tumor growth and progression in vivo | Q72149266 | ||
| The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis | Q72692111 | ||
| p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! | Q72730267 | ||
| Forms and functions of p53 | Q72776249 | ||
| Mutations of the p53 gene do not occur in testis cancer | Q72851846 | ||
| Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition | Q73034002 | ||
| P4510 | describes a project that uses | OU-AML-1 | Q54936738 |
| OU-AML-2 | Q54936739 | ||
| OU-AML-3 | Q54936740 | ||
| OU-AML-4 | Q54936741 | ||
| OU-AML-5 | Q54936744 | ||
| OU-AML-6 | Q54936745 | ||
| OU-AML-7 | Q54936746 | ||
| OU-AML-8 | Q54936748 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| cell line | Q21014462 | ||
| P304 | page(s) | 407-415 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | p53 status of newly established acute myeloid leukaemia cell lines | |
| P478 | volume | 79 |
| Q40955900 | An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukaemia cells |
| Q29303646 | False leukemia–lymphoma cell lines: an update on over 500 cell lines |
| Q27021173 | High-dimensional single-cell cancer biology |
| Q46307051 | Mapping normal and cancer cell signalling networks: towards single-cell proteomics |
| Q40715498 | Superior effect of 9-cis retinoic acid (RA) compared with all-trans RA and 13-cis RA on the inhibition of clonogenic cell growth and the induction of apoptosis in OCI/AML-2 subclones: is the p53 pathway involved? |
| Q26766341 | Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy |
| Q40771798 | p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death |
Search more.